
CASE DISCUSSION
Diabetes and Renal Impairment : Let's Understand the Link
Presented from India by Dr. Sumon Chowdhary0
Likes
3671
Views
147
Shares
147
Bookmarks
0
Credit Points
0
Learning Hours
0
CPD/CME Points
0
Courses Completed
Case Description
Individuals with diabetes often develop kidney disease or damage over time. We refer to this kind of kidney disease as diabetic nephropathy. Nephrons in diabetics gradually thicken and get damaged over time. Urine starts to contain protein (albumin) due to nephron leaks. This damage may occur years...
Case Summary
- Dr. Shuman Nauhan from Troll 3 presented a webinar on diabetes and renal impairment, highlighting the increasing burden of chronic diseases like hypertension and diabetes in India and Bangladesh. India has a diabetic population of around 61.3 million, while Bangladesh has 13.1 million. A significant percentage (25-40%) of these individuals develop end-stage renal disease (ESRD). Key features of diabetic nephropathy include increasing urinary albumin expression, rising blood urea nitrogen (BUN), and declining renal functionalities.
Speaker Profile

Dr. Sumon Chowdhary
Endocrinologist, Chittagong Diabetic General Hospital, BangladeshDr. Sumon Chowdhury is a Consultant in Endocrinology at Chittagong Diabetic General Hospital in Bangladesh. He specializes in the diagnosis and management of hormonal and metabolic disorders, including diabetes, thyroid diseases, and other endocrine conditions. With a strong commitment to patient-centered care, he focuses on providing evidence-based treatment and long-term disease management. Dr. Chowdhury is also actively involved in promoting diabetes awareness and improving endocrinology services within the community.
Disclosures
Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.